| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8939567 | British Journal of Anaesthesia | 2006 | 8 Pages |
Abstract
Systemic injections of TTX diminished pain behaviour in a dose-dependent manner in models of inflammatory, visceral and neuropathic pain without causing adverse events, whereas morphine analgesia was associated with heavy sedation. TTX is a very promising substance for the treatment of various types of pain but needs further evaluation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
J. Marcil, J.-S. Walczak, J. Guindon, A.H. Ngoc, S. Lu, P. Beaulieu,